You are here

  • Home
  • Online First
  • What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?

Article info

Article menu

other Versions

Download PDFPDF
Commentary
What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?

Authors

  • Thales Paulo Batista Surgery, Federal University of Pernambuco, Recife, Pernambuco, BrazilSurgery/Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Pernambuco, Brazil PubMed articlesGoogle scholar articles
  • Heng-Cheng Hsu Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Thales Paulo Batista, Surgery, UFPE, Recife 50670-901, Pernambuco, Brazil; t.paulo{at}outlook.com

Citation

Batista TP, Hsu H
What have we learned after four randomized controlled trials on neoadjuvant chemotherapy for ovarian cancer?
International Journal of Gynecologic Cancer Published Online First: 24 December 2020. doi: 10.1136/ijgc-2020-002268

Publication history

  • Received November 20, 2020
  • Revision received December 2, 2020
  • Accepted December 4, 2020
  • First published December 24, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.